Standards message here

Solid Tumors

Sarcoma and Soft Tissue

1

Disease Status and/or Stage Progressive Disease After Therapies with Curative Potential or Approved Salvage Regimen.
Protocol Title Phase I/II, Open-Label, Dose Escalation Study of CDX-1401 in Patients with Malignances Known to Express NY-ESO-1
PI Ellen Chaung, MD
Contact June Greenberg, RN
212-746-2651
  Last updated: January 5, 2011
© Weill Medical College of Cornell University
Home | Privacy Notice | Disclaimer

 

 

© Weill Medical College of Cornell University
Home | Privacy Notice | Disclaimer